COVID-19 and metabolism-targeted therapeutic interventions
Coronavirus

Different approaches are possible:

• PPP inhibition to reduce ribose production
  • Can a metabolism-targeted therapeutic intervention successfully subjugate SARS-COV-2? A scientific rational, 2020
    • Owing to the more metabolic plasticity of uninfected cells, a promising approach for specific antiviral therapy, which has drawn a lot of attention in the recent years, would be the targeting of metabolic changes induced by viruses. In the current review, we first summarize some of virus-induced metabolic adaptations and then based on these information as well as SARS-CoV-2 pathogenesis, propose a potential therapeutic modality

Microbiota and COVID-19

Seven secrets of COVID-19: fever, ACE2 receptors, gut-lung axis, metabolomics, microbiomics, probiotics, diet

Potential implications of SARS-CoV-2 oral infection in the host microbiota

Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response,